Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane

被引:53
作者
Barceló, S
Macé, K
Pfeifer, AMA
Chipman, JK
机构
[1] Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England
[2] Aston Univ, Dept Pharmaceut Sci, Birmingham B4 7ET, W Midlands, England
[3] Nestle Res Ctr, CH-1000 Lausanne, Switzerland
关键词
sulforaphane; comet assay; CYP1A2; CYP2E1; chemoprevention;
D O I
10.1016/S0027-5107(97)00288-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The production of DNA strand breaks by N-nitrosodimethylamine (NDMA) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) has been observed in T5-2E1 (expressing human CYP2E1) and T5-1A2 (expressing human CYP1A2) human liver cells respectively, using the Comet assay. Responses were statistically significant (P < 0.05) and concentration dependent (0.01-1 mu g ml(-1) NDMA and 0.1-10 mu g ml(-1) IQ) and were not observed in TS-neo cells devoid of cytochrome P450 activity. Sulforaphane (1-isothiocyanate-4-methylsulfinylbutane) (0.1-10 mu M) gave a marked inhibition of DNA strand breakage by these carcinogens (P < 0.05 linear regression). This was seen in the absence of cytotoxicity and in the absence of an inhibition of H2O2-induced DNA strand breakage. The ability of sulforaphane to inhibit both CYP2E1 and CYP1A2-mediated genotoxicity therefore is relevant to human isoforms of these enzymes and may contribute to a chemopreventative activity. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
[1]   THE SINGLE-CELL GEL-ELECTROPHORESIS ASSAY FOR INDUCED DNA-DAMAGE (COMET ASSAY) - MEASUREMENT OF TAIL LENGTH AND MOMENT [J].
ASHBY, J ;
TINWELL, H ;
LEFEVRE, PA ;
BROWNE, MA .
MUTAGENESIS, 1995, 10 (02) :85-90
[2]   CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane [J].
Barcelo, S ;
Gardiner, JM ;
Gescher, A ;
Chipman, JK .
CARCINOGENESIS, 1996, 17 (02) :277-282
[3]  
BARCELO S, 1997, IN PRESS MUTAGENEIS
[4]   Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes [J].
Bellec, G ;
Dreano, Y ;
Lozach, P ;
Menez, JF ;
Berthou, F .
CARCINOGENESIS, 1996, 17 (09) :2029-2034
[5]   INTERACTION BETWEEN 2 PROBES USED FOR PHENOTYPING CYTOCHROMES P4501A2 (CAFFEINE) AND P4502E1 (CHLORZOXAZONE) IN HUMANS [J].
BERTHOU, F ;
GOASDUFF, T ;
LUCAS, D ;
DREANO, Y ;
LEBOT, MH ;
MENEZ, JF .
PHARMACOGENETICS, 1995, 5 (02) :72-79
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   GENOTYPING FOR POLYMORPHISMS IN XENOBIOTIC METABOLISM AS A PREDICTOR OF DISEASE SUSCEPTIBILITY [J].
DALY, AK ;
CHOLERTON, S ;
ARMSTRONG, M ;
IDLE, JR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 :55-61
[8]  
DAVIES JE, 1995, MUTAGENESIS, V10, P576
[9]  
DEFLORA S, 1995, DRUGS DIET DIS, V1
[10]   A MICROASSAY FOR MEASURING CYTOCHROME-P450IA1 AND CYTOCHROME-P450IIB1 ACTIVITIES IN INTACT HUMAN AND RAT HEPATOCYTES CULTURED ON 96-WELL PLATES [J].
DONATO, MT ;
GOMEZLECHON, MJ ;
CASTELL, JV .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (01) :29-33